Brief: Quia Pharma Gets Notice Of Objection From Nasdaq Requesting Delisting

QUIA PHARMA AB (publ)

25/11/2024 14:40

Nov 25 (Reuters) - QUIA PHARMA AB (publ)  QUIA.ST :
    * HAS RECEIVED NOTICE OF OBJECTION FROM NASDAQ REQUESTING
DELISTING
    * NASDAQ CONSIDERS THAT CO HAS FAILED IN ITS DISCLOSURE OF
INFORMATION
    * MATTER WILL BE REFERRED TO NASDAQ'S DISCIPLINARY COMMITTEE
AFTER
CO HAS BEEN TO RESPOND TO ALLEGATIONS
    * NASDAQ WILL REQUEST DISCIPLINARY COMMITTEE TO DECIDE TO
DELIST
CO'S SHARES FROM NASDAQ FIRST NORTH GROWTH MARKET

Source text:  ID:nMFN73XbCM 
Further company coverage:  QUIA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))